Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jul 13 2022

Full Issue

Opioid Makers Teva, Allergan To Pay San Francisco $54 Million Settlement

As part of the settlement, about $34 million in cash will be handed to the city, plus $20 million worth of Narcan, which can treat overdoses in emergency situations. In New Mexico, AP reports that doctors are pressing legislators to permit use of psychedelic mushrooms for mental health therapies.

San Francisco Chronicle: Opioid Manufacturers Agree To Pay San Francisco $54 Million In Groundbreaking Case

Opioid manufacturers Allergan and Teva have agreed to pay San Francisco $54 million in cash and curative products to settle claims that they were responsible for drug addictions and deaths, leaving Walgreens, which sells the opioids, as the only defendant in the city’s groundbreaking federal court trial. The trial was wrapping up with closing statements Tuesday. (Egelko, 7/12)

In other health news from across the U.S. —

AP: Doctors Urge Access To Psychedelic Therapies In New Mexico

Physicians and researchers are urging New Mexico legislators to allow the use of psychedelic mushrooms in mental health therapy aimed at overcoming depression, anxiety, psychological trauma and alcoholism. A legislative panel on Tuesday listened to advocates who hope to broaden the scope of medical treatment and research assisted by psilocybin, the psychedelic active ingredient in certain mushrooms. Oregon is so far the only state to legalize the therapeutic use of psilocybin. (Lee, 7/13)

AP: Judge: NC Voters With Disabilities Can Choose Who Help Them 

A federal judge has blocked North Carolina laws that greatly restrict who can help people with disabilities request absentee ballots, fill them out and return them. A disabled person needing help to vote by mail can now seek assistance from anyone they choose, not just from a close relative or legal guardian as state law has limited, the State Board of Elections told county election officials after the decision filed Monday by U.S. District Judge Terrence Boyle. (Robertson, 7/12)

Chicago Tribune: Gov. J.B. Pritzker Names New State Public Health Director

Gov. J.B. Pritzker on Tuesday appointed a professor from the Southern Illinois University School of Medicine to lead the state Department of Public Health as highly contagious coronavirus variants have emerged and made clear the pandemic is far from over. (Petrella, 7/12)

New Hampshire Public Radio: Shibinette To Resign As N.H. Health Commissioner

New Hampshire Health and Human Services Commissioner Lori Shibinette, who spent much of her two-and-a-half-year tenure responding to the impacts of the COVID-19 pandemic, is planning to step down later this year. (Fam and Furukawa, 7/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF